These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26050385)

  • 1. The use of antiretroviral therapy for the prevention of new HIV infection in populations at high risk for HIV sero-conversion in Nigeria.
    Idoko J; Folayan MO
    Afr J Reprod Health; 2014 Sep; 18(3 Spec No):127-34. PubMed ID: 26050385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Why should I take drugs for your infection?": outcomes of formative research on the use of HIV pre-exposure prophylaxis in Nigeria.
    Idoko J; Folayan MO; Dadem NY; Kolawole GO; Anenih J; Alhassan E
    BMC Public Health; 2015 Apr; 15():349. PubMed ID: 25881087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling the impact and cost-effectiveness of combination prevention amongst HIV serodiscordant couples in Nigeria.
    Mitchell KM; Lépine A; Terris-Prestholt F; Torpey K; Khamofu H; Folayan MO; Musa J; Anenih J; Sagay AS; Alhassan E; Idoko J; Vickerman P
    AIDS; 2015 Sep; 29(15):2035-44. PubMed ID: 26355574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiretroviral drugs-based HIV prevention methods: what impact on the HIV epidemic?].
    Supervie V
    Med Sci (Paris); 2013 Apr; 29(4):373-82. PubMed ID: 23621932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention.
    Morton JF; Celum C; Njoroge J; Nakyanzi A; Wakhungu I; Tindimwebwa E; Ongachi S; Sedah E; Okwero E; Ngure K; Odoyo J; Bulya N; Haberer JE; Baeten JM; Heffron R;
    J Acquir Immune Defic Syndr; 2017 Jan; 74 Suppl 1(Suppl 1):S15-S22. PubMed ID: 27930607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.
    Patel RC; Stanford-Moore G; Odoyo J; Pyra M; Wakhungu I; Anand K; Bukusi EA; Baeten JM; Brown JM
    J Int AIDS Soc; 2016; 19(1):21134. PubMed ID: 27964776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Willingness of Kenyan HIV-1 serodiscordant couples to use antiretroviral-based HIV-1 prevention strategies.
    Heffron R; Ngure K; Mugo N; Celum C; Kurth A; Curran K; Baeten JM
    J Acquir Immune Defic Syndr; 2012 Sep; 61(1):116-9. PubMed ID: 22595872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PrEP Discontinuation and Prevention-Effective Adherence: Experiences of PrEP Users in Ugandan HIV Serodiscordant Couples.
    Gilbert HN; Wyatt MA; Pisarski EE; Muwonge TR; Heffron R; Katabira ET; Celum CL; Baeten JM; Haberer JE; Ware NC
    J Acquir Immune Defic Syndr; 2019 Nov; 82(3):265-274. PubMed ID: 31609925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethics of ARV based prevention: treatment-as-prevention and PrEP.
    Haire B; Kaldor JM
    Dev World Bioeth; 2013 Aug; 13(2):63-9. PubMed ID: 23594312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 Treatment-as-Prevention: A Cohort Study Analysis of Serodiscordant Couples in Rural Southwest China.
    Tang Z; Lan G; Chen YQ; Zhu Q; Yang X; Shen Z; Chen Y; Zhang H; Kan W; Xing H; Ruan Y; Shao Y
    Medicine (Baltimore); 2015 Jun; 94(24):e902. PubMed ID: 26091454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States: opportunities and challenges.
    McMahon JM; Myers JE; Kurth AE; Cohen SE; Mannheimer SB; Simmons J; Pouget ER; Trabold N; Haberer JE
    AIDS Patient Care STDS; 2014 Sep; 28(9):462-74. PubMed ID: 25045996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of three delivery models for promoting access to pre-exposure prophylaxis in HIV-1 serodiscordant couples in Nigeria.
    Folayan MO; Aliyu S; Oginni A; Ezechi O; Kolawole G; Ezeama N; Dadem N; Anenih J; Alagi M; Ekanem E; Afiadigwe E; Aguolu R; Oyebode T; Babalola-Jacobs A; Sagay A; Nweneka C; Kamofu H; Idoko J
    PLoS One; 2022; 17(5):e0268011. PubMed ID: 35511948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition--United States, 2015.
    Smith DK; Van Handel M; Wolitski RJ; Stryker JE; Hall HI; Prejean J; Koenig LJ; Valleroy LA
    MMWR Morb Mortal Wkly Rep; 2015 Nov; 64(46):1291-5. PubMed ID: 26606148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral therapy for prevention of HIV transmission: potential role for people who inject drugs in Central Asia.
    McNairy ML; Deryabina A; Hoos D; El-Sadr WM
    Drug Alcohol Depend; 2013 Nov; 132 Suppl 1():S65-70. PubMed ID: 23880248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A practical online tool to estimate antiretroviral coverage for HIV infected and susceptible populations needed to reduce local HIV epidemics.
    Chaillon A; Hoenigl M; Mehta SR; Weibel N; Little SJ; Smith DM
    Sci Rep; 2016 Jun; 6():28707. PubMed ID: 27337983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review of HIV treatment adherence research among people who inject drugs in the United States and Canada: evidence to inform pre-exposure prophylaxis (PrEP) adherence interventions.
    Bazzi AR; Drainoni ML; Biancarelli DL; Hartman JJ; Mimiaga MJ; Mayer KH; Biello KB
    BMC Public Health; 2019 Jan; 19(1):31. PubMed ID: 30621657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of the transmission dynamics of the HIV/AIDS epidemic on sexual behaviour: a new hypothesis to explain recent increases in risk taking-behaviour among men who have sex with men.
    Boily MC; Godin G; Hogben M; Sherr L; Bastos FI
    Med Hypotheses; 2005; 65(2):215-26. PubMed ID: 15922091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of treatment as prevention for HIV and continuum of care among HIV-positive men who have sex with men in Nigeria.
    Charurat ME; Emmanuel B; Akolo C; Keshinro B; Nowak RG; Kennedy S; Orazulike I; Ake J; Njoku O; Baral S; Blattner W;
    J Acquir Immune Defic Syndr; 2015 Mar; 68 Suppl 2(Suppl 2):S114-23. PubMed ID: 25723975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preexposure prophylaxis for the prevention of HIV transmission to women.
    Aaron E; Cohan D
    AIDS; 2013 Jan; 27(1):F1-5. PubMed ID: 22914582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.